Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 848-849    DOI: 10.12891/ceog5033.2019
Case Report Previous articles |
Parasitic abdominal wall leiomyoma after open myomectomy
L. Giannella1, *(), S. Paganelli2, L. Sabbioni1, L.B. Cerami1
1Local Health Authority of Reggio Emilia-IRCCS, Obstetrics and Gynecology Unit, Cesare Magati Hospital, Scandiano, Italy
2Local Health Authority of Reggio Emilia-IRCCS, Gynecology Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
Download:  PDF(575KB)  ( 196 ) Full text   ( 5 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Parasitic abdominal wall leiomyoma (AWL) is a rare event after myomectomy. In the literature, this occurrence was reported after a laparoscopic approach with an incidence of less than 1%. The present authors report an unusual case of parasitic AWL after open myomectomy in a 46-year-old woman. Also during a laparotomy, where fibroids are usually removed intact, particular care is mandatory to avoid myoma fragments in the surgical scar. Furthermore, differential diagnosis of an abdominal wall neoformation after laparotomy for fibroid removal should include the occurrence of a parasitic myoma.

Key words:  Open myomectomy      Parasitic myoma      Abdominal wall leiomyoma     
Published:  10 October 2019     
*Corresponding Author(s):  L. GIANNELLA     E-mail:  lucazeta1976@libero.it

Cite this article: 

L. Giannella, S. Paganelli, L. Sabbioni, L.B. Cerami. Parasitic abdominal wall leiomyoma after open myomectomy. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 848-849.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog5033.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I5/848

No related articles found!
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .